Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-28 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm |
9,096 | $0.67 | 64,924 (Direct) |
View |
2025-02-28 Exercise |
2025-03-03 4:30 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm |
24,673 | $0 | 64,924 (Direct) |
View |
2025-02-13 Option Award |
2025-02-18 4:20 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Comm |
961,420 | $0 | 961,420 (Direct) |
View |
Ownership |
2024-10-07 4:58 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Strategy |
0 | $0 | 378,040 (Direct) |
View |
2021-12-31 Tax Withholding |
2022-01-04 4:18 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | DeFrancesco Lisa SVP, IR & Corp. Affairs |
542 | $16.29 | 10,308 (Direct) |
View |
2021-09-30 Tax Withholding |
2021-10-04 5:04 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | DeFrancesco Lisa SVP, IR & Corp. Affairs |
204 | $14.85 | 10,850 (Direct) |
View |
2021-09-01 Tax Withholding |
2021-09-03 7:00 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | DeFrancesco Lisa SVP, IR & Corp. Affairs |
538 | $15.05 | 11,054 (Direct) |
View |
Ownership |
2021-02-17 7:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | DeFrancesco Lisa SVP, IR & Corp. Affairs |
0 | $0 | 25,617 (Direct) |
View |